Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.6.355

Preparation of Dexamethasone-21-palmitate Incorporated Lipid Nanosphere: Physical Properties by Varying Components and Ratio of Lipid  

Jung, Suk-Hyun (Bioactive Molecules Delivery & Control Team, Korea Research Institute of Chemical Technology)
Lee, Jung-Eun (Bioactive Molecules Delivery & Control Team, Korea Research Institute of Chemical Technology)
Seong, Ha-Soo (Bioactive Molecules Delivery & Control Team, Korea Research Institute of Chemical Technology)
Shin, Byung-Cheol (Bioactive Molecules Delivery & Control Team, Korea Research Institute of Chemical Technology)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.6, 2006 , pp. 355-361 More about this Journal
Abstract
Intraarticular corticosteroid injections for therapy of rheumatic arthritis are administered with the aim of optimal local anti-inflammatory effect at the injection site. Since the side effects of corticosteroidal drug, dexamethasone(DEX), administered at hish dose limited the therapeutic efficacy, there was a need to design a new drug delivery system for controlled release of dexamethasone. As a prodrug for continuous therapeutic efficacy, dexamethasone-21-palmitate(DEX-PAL) was prepared via esterification of palmitoyl chloride and dexamethasone. DEX-PAL was identified by NMR and MASS analysis. DEX-PAL or DEX was entrapped in lipid nanosphere which could be prepared by using a self emulsification-solvent evaporation method. Physicochemical characteristics such as mean particle diameter, zeta potential and drug loading efficiency of the lipid nanospheres were investigated with variation of either the kind of lipid or the lipid composition. The lipid nanospheres had a mean diameter $83{\sim}95$ nm and DEX-PAL loading efficiency of up to 95%. The drug loading efficiency increased with the increase of aliphatic chain length attached to the phospholipid. The incorporation of cationic lipid was very efficient for both reducing particle size of lipid nanospheres and enhancing drug loading efficiency. The lipid nanospheres containing DEX-PAL may be a promising novel drug carrier for the controlled release of the poorly water-soluble drugs.
Keywords
Dexamethasone-21-palmitate(DEX-PAL); Lipid nanosphere; Controlled release formulation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 O. F. Turkoglu, H. Eroglu, O. Okutan, E. Burul, M. F. Sargon, N. Ozer, L. Oner and E. Beskonakli, The efficiency of dexamethasone sodium phosphate-encapsulated chitosan microspheres after cold injury, Surg. Neurol., 64, S2:11-S2:16 (2005)
2 B. McCormack and G. Gregoriadis, Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-b-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery, Biochim. Biophys. Acta., 1291, 237-244 (1996)   DOI   ScienceOn
3 G. Hochhaus, H. Derendorf, H. M쉕lmann and J. Barth, A selective LC/RIA for dexamethasone and its prodrug dexamethasone-21-isonicotinate in biological fluids, J. Pharmaceut. Biomed., 9, 761-767 (1991)   DOI   ScienceOn
4 H. Murakami, M. Kobayashi, H. Takeuchi and Y. Kawashima, Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int. J. Pharm., 187, 143-152 (1999)   DOI   ScienceOn
5 Y. Tauchi, M. Takase, I. Zushida, S. Chono, J. Sato, K. Ito and K. Morimoto, Preparation of a complex of dexame- thasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages, J. Pharm. Sci., 88, 709-714 (1999)   DOI
6 T. Niwa, H. Takeuchi, T. Hino, N. Kunou and Y. Kawashima, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior, J. Control. Rel., 25, 89-98 (1993)   DOI   ScienceOn
7 A. Z. Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism, Eur. J. Pharm. Biopharm., 45, 149-155 (1998)   DOI   ScienceOn
8 Ministry of Health and Welfare, The Korea Pharmacopoeia, seventh edition 71-72
9 S.A. Wissing and O. Kayser, R.H. Solid lipid nanoparticles for parenteral drug delivery Muller, Adv. Drug. Deliver. Rev., 56, 1257-1272 (2004)   DOI   ScienceOn
10 C. X. Song, V. Labhasetwar, H. Murphy, X. Qu, W. R. Humphrey, R. J. Shebuski and R. J. Levy, Formulation and characterization of biodegradable nanoparticles for intrava-scular local drug delivery, J. Control. Release., 43, 197-212 (1997)   DOI   ScienceOn
11 H. Fukui, T. Koike, A. Saheki, S. Sonoke and J. Seki, A novel delivery system for amphotericin B with lipid nano-sphere ($LNS^{\circledR}$), Int. J. Pharm., 265, 37-45 (2003)   DOI   ScienceOn
12 M. H. Bonanomi, M. Velvart, M. Stimpel, K. M. Roos, K. Fehr and H. G. Weder, Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis, Rheumatol Int., 7, 203-212 (1987)   DOI
13 A. R. Mohammed, N. Weston, A. G. A. Coombes, M. Fitzgerald and Y. Perrie, Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability, Int. J. Pharm., 285, 23-34 (2004)   DOI   ScienceOn
14 A. Sanchez, J. L. Vila-Jato and M. J. Alonso, Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A, Int. J. Pharm., 99, 263-273 (1993)   DOI   ScienceOn
15 G. Cevc and G. Blume, Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect and reduced therapeutic dosage, Biochim. Biophys. Acta., 1663, 61-73 (2004)   DOI   ScienceOn